5 pc increase in sales for Roche Group in H1

Swiss pharma group Roche reported an increase in their global sales in the first half of the year by 5 percent, at a constant exchange rate, reaching CHF 22.9 billion due to the increased demand for cancer and autoimmune drugs, reports a press relese. According to Severin Schwan, Roche CEO, the good results are due to the performance of the cancer drugs, especially those against breast cancer, and the diagnostic division. The R&D division reported major progress as well both in Pharma and Diagnostic areas. )…) Considering the performance of Roche Group over the first six months, I am sure we will meet our targets for 2014,” stressed Schwan. For the current year, Roche forecasts an increase in sales of about 5 percent, for a constant exchange rate and higher dividends.

Related posts

EUR 4.9 bln, Romania’s hard currency reserve in April 2012

Nine O' Clock

OSF Global continues its Romanian and global expansion, opens two new offices in Pitesti and Craiova

Nine O' Clock

Tax Agency declares EUR 1.7 bln-damages to state budget